SmofKabiven/SmofKabiven Peripheral

SmofKabiven/SmofKabiven Peripheral Overdosage

Manufacturer:

Fresenius Kabi

Distributor:

Zuellig Pharma
Full Prescribing Info
Overdosage
SmofKabiven: See "Fat overload syndrome", "Excess of amino acid infusion" and "Excess of glucose infusion" under Adverse Reactions.
If symptoms of overdose of lipids or amino acids occur, the infusion should be slowed down or discontinued. There is no specific antidote for overdose. Emergency procedures should be general supportive measures, with particular attention to respiratory and cardiovascular systems. Close biochemical monitoring would be essential and specific abnormalities treated appropriately.
If hyperglycaemia occurs, it should be treated according to the clinical situation either by appropriate insulin administration and/or adjustment of the infusion rate.
Additionally, overdose might cause fluid overload, electrolyte imbalances and hyperosmolality. In some rare serious cases, haemodialysis, haemofiltration or haemo-diafiltration may be considered.
Sign up for Free to continue reading
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in